Learning Objectives
Upon completion of this activity, participants should be able to:
Describe the potential clinical benefits and risks associated with the use of nucleoside analogues in patients with decompensated HBV liver disease
Outline the potential role of tenofovir in the treatment of chronic HBV infection
Review data on the use of immunoprophylaxis to prevent HBV recurrences after liver transplantation
Test your ability to provide optimal clinical management for decompensated patient with chronic hepatitis B.